Utility of S100B Serum Level for the Determination of Concussion in Male Rugby Players

Damien Bouvier (1, 2) , Thomas Duret , Mathieu Abbot , Thibault Stiernon , Bruno Pereira (3) , Aurélien Coste (4) , Jean Chazal (5) , Vincent Sapin (6)

1 GReD - Génétique, Reproduction et Développement
2 UCA [2017-2020] - Université Clermont Auvergne [2017-2020]
3 DRCI - Direction de la recherche clinique et de l’innovation [CHU Clermont-Ferrand]
4 Service de Neurochirurgie [CHU Clermont-Ferrand]
5 ERIM-ERI 14 - Equipe de Recherche en Signal et Imagerie Medicale
6 Laboratoire de Biochimie

The incidence of concussion in professional direct-contact sports, particularly in rugby, has increased in recent years. To date, cognitive assessment is the most common means of determining whether a concussed player can return to the game. Serum S100B assay, an objective blood test known to be useful in brain injury management, may offer a novel additional approach to the management of concussed male rugby players.

Domaines: Sciences du Vivant [q-bio]

Damien Bouvier, Thomas Duret, Mathieu Abbot, Thibault Stiernon, Bruno Pereira, et al.. Utility of S100B Serum Level for the Determination of Concussion in Male Rugby Players. Sports Medicine, 2017, 47 (4), pp.781 - 789. ⟨10.1007/s40279-016-0579-9⟩. ⟨hal-01919755⟩